Company intelligence / Profile preview

Sage Labs

St. Louis, Missouri, United States

Ownership: Private
Employees: ~50
Development stage: Other

Overview

Sage Labs was a commercial provider of next-generation in vivo transgenic research models and services, generating complex genetically modified animal models (mice, rats, rabbits) in approximately half the time compared to conventional technologies.

Therapeutic areas: OncologyRare Diseases
Modalities: Gene therapyCRISPR-based therapy
Industry: Non-Drug Biotech

Partnerships

Cofactor Genomics (RNA-sequencing services partnership)

Beyond the preview

Go deeper on Sage Labs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sage Labs.

Explore the full profile